Our Members

As a member-focused Association, our members are at the heart of everything we do at the PRI.

In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.

Find out more about the different ways you and your organization can get involved with the PRI’s activities.

  • Microbiome Regulatory Science Support Work
  • Pre-competitive Task Groups
  • Year-round networking and project-related communication support

More than 100 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.

5QBD-Biotech

5QBD-Biotech

Frédérique Vieville

CEO

Our company's aim is to secure and speed up any drug development and manufacturing chain, from the bench to the Clinic.

Accelsiors AG

Accelsiors AG

Hélène Cvejic

Director Translational Science and Clinical Research Hubs

Accelsiors is a leading international CRO. We support and accelerate each step of the clinical drug development, from the preclinical consultation stage throughout the whole clinical development.

 

AcuraBio

AcuraBio

Max Rossetto

Head Business Development

Biopharma Development and Manufacturing Services - AcuraBio is an Australia-based contract development and manufacturing organization (CDMO) that provides development and biomanufacturing to the pharmaceutical, biotechnology, and veterinary industries.

 

Adare Pharma Solutions

Adare Pharma Solutions

Gilles Chauvière

Managing Director, Microbiome Science & Technology

 

 

Adiso therapeutics

Adiso therapeutics

Laurent Chesnel

VP Research and Development

Adiso is a clinical-stage biopharmaceutical company advancing an innovative pipeline of small molecules and single strain live biotherapeutic products (SS-LBP) to treat inflammatory diseases.

 

ADM

ADM

Ana Enriquez

Regulatory Affairs & Compliance Director - H&W

As one of the world’s largest nutrition companies, ADM is a leader in both human and animal nutrition.

 

Alveolus Bio

Alveolus Bio

C. Vivek Lal

Founder & CEO

Pioneering breakthrough FDA-approved therapeutics for lung diseases. Our pipeline includes preclinical phase live biotherapeutics for Chronic Obstructive Pulmonary Disease (COPD), Lung Injury Secondary to Viral Illness, Bronchopulmonary Dysplasia (BPD), Neutrophilic Asthma, and earlier stage programs, including Pulmonary Arterial Hypertension (PAH), Acute Respiratory Distress Syndrome, and Idiopathic Pulmonary Fibrosis.

 

Animalcare Ltd.

Animalcare Ltd.

Rachel Smithson

General Manager UK

Veterinary pharmaceutical business. Focused on growing our business sustainably, bringing new and innovative animal health products to market through our development pipeline, partnerships and acquisitions.